Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Yong Park

Showing results (1-10 of 444) with videos related to

Pageof 45
Sort By:
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|April 24, 2019
New Concept of Hepatocellular Carcinoma Treatment with the Tumor Suppressor 'WDR76' through 'RAS' DegradationJun Yong Park
Hepatobiliary Surgery and Nutrition|December 20, 2023
Surveillance for hepatocellular carcinoma in non-alcoholic fatty liver disease patients: towards personalized risk stratificationKunhee Kim, Jun Yong Park
World Journal of Gastroenterology|June 27, 2014
When to stop nucleos(t)ide analogues treatment for chronic hepatitis B? Durability of antiviral responseWonseok Kang, Jun Yong Park
Biomed Research International|January 24, 2014
Clinical significance of AFP and PIVKA-II responses for monitoring treatment outcomes and predicting prognosis in patients with hepatocellular carcinomaHana Park, Jun Yong Park
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|September 26, 2012
Prediction of minimal hepatic encephalopathySangheun Lee, Jun Yong Park
Journal of Gastroenterology and Hepatology|April 16, 2008
Chemotherapy for advanced hepatocellular carcinomaKwang-Hyub Han, Jun Yong Park
Cancer Cell International|January 6, 2017
Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interferenceSung Hoon Choi, Jun Yong Park
Hepatobiliary Surgery and Nutrition|November 2, 2019
Overview of emerging treatment of non-alcoholic fatty liver disease: more than one drug needed?Dong Yun Kim, Jun Yong Park
Expert Opinion on Pharmacotherapy|August 16, 2021
Besifovir dipivoxil maleate: a novel antiviral agent with low toxicity and high genetic barriers for chronic hepatitis BJeong Eun Song, Jun Yong Park
The American Journal of Gastroenterology|September 7, 2017
Reply to Huang et alYoung Eun Chon, Jun Yong Park
Pageof 45

Showing results (1-10 of 444) with videos related to

Sort By:
Pageof 45
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|April 24, 2019
New Concept of Hepatocellular Carcinoma Treatment with the Tumor Suppressor 'WDR76' through 'RAS' DegradationJun Yong Park
Hepatobiliary Surgery and Nutrition|December 20, 2023
Surveillance for hepatocellular carcinoma in non-alcoholic fatty liver disease patients: towards personalized risk stratificationKunhee Kim, Jun Yong Park
World Journal of Gastroenterology|June 27, 2014
When to stop nucleos(t)ide analogues treatment for chronic hepatitis B? Durability of antiviral responseWonseok Kang, Jun Yong Park
Biomed Research International|January 24, 2014
Clinical significance of AFP and PIVKA-II responses for monitoring treatment outcomes and predicting prognosis in patients with hepatocellular carcinomaHana Park, Jun Yong Park
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|September 26, 2012
Prediction of minimal hepatic encephalopathySangheun Lee, Jun Yong Park
Journal of Gastroenterology and Hepatology|April 16, 2008
Chemotherapy for advanced hepatocellular carcinomaKwang-Hyub Han, Jun Yong Park
Cancer Cell International|January 6, 2017
Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interferenceSung Hoon Choi, Jun Yong Park
Hepatobiliary Surgery and Nutrition|November 2, 2019
Overview of emerging treatment of non-alcoholic fatty liver disease: more than one drug needed?Dong Yun Kim, Jun Yong Park
Expert Opinion on Pharmacotherapy|August 16, 2021
Besifovir dipivoxil maleate: a novel antiviral agent with low toxicity and high genetic barriers for chronic hepatitis BJeong Eun Song, Jun Yong Park
The American Journal of Gastroenterology|September 7, 2017
Reply to Huang et alYoung Eun Chon, Jun Yong Park
Pageof 45